<DOC>
	<DOCNO>NCT01149304</DOCNO>
	<brief_summary>To evaluate whether combination regimen pentoxifylline , ursodeoxycholic acid enoxaparin provide protective effect liver parenchyma high dose rate ( HDR ) brachytherapy .</brief_summary>
	<brief_title>Preventive Effect Enoxaparin , Pentoxifylline Ursodeoxycholic Acid Radiation Induced Liver Toxicity</brief_title>
	<detailed_description>A preventive effect pentoxifylline , ursodeoxycholic acid low dose low molecular weight heparin pathological process healthy tissue irradiation describe clinical study percutaneous liver irradiation bone marrow transplantation . However , data remains inconclusive . This exploratory study aim assess whether protective effect combination pentoxifylline , ursodeoxycholic acid enoxaparin demonstrate limited number patient liver metastasis colorectal cancer HDR brachytherapy . All patient receive single fraction CT/MRI-guided HDR-brachytherapy colorectal liver metastases use Iridium-192 standard therapy . The follow-up consist 4 MRI control abdomen use hepatocyte-specific contrast agent Gd-EOB-DTPA ( Primovist ) 3 day , 6 week , 3 month 6 month well blood sample questionnaire take time.Within study , 22 patient give low dose low molecular weight heparin , pentoxifylline ursodeoxycholic acid 8 week start preinterventional day . Another 22 patient receive standard therapy without medication . After completion follow-up , MRI volume data lesion acquire compare dosimetric treatment plan . Blood sample test liver-specific inflammatory laboratory parameter .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>Age 18 80 If female , postmenopausal surgically sterilize Liver metastases colorectal carcinoma schedule CT/MRIguided singlefraction interstitial HDR brachytherapy Noncirrhotic liver Life expectancy longer 6 month willing able undergo study procedure Having voluntarily provide write fully inform consent Women pregnant , lactate childbearing potential Liver cirrhosis Hepatitis B Hepatitis C Patients clinically unstable Uncooperative , investigator 's opinion Having previously enrol study Participating another therapymodulating clinical trial Contraindication MRI Contraindication hypersensitivity one component GdEOBDTPA , Enoxaparin , Ursodeoxycholic acid and/or Pentoxifylline Any prior irradiation therapy liver Close affiliation investigational site ; e.g . close relative investigator Severe coronary artery disease Autoimmune diseases Acute bacterial endocarditis Active major bleeding high rish uncontrolled haemorrhage Patients severe moderate renal impairment ( GFR 60 mL/min/1.73 m2 accord MDRD CockroftGault formula , calculate creatinine value obtain within 1 week plan Primovistenhanced MR examination )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>brachytherapy</keyword>
	<keyword>liver metastasis</keyword>
	<keyword>irradiation</keyword>
	<keyword>radiation induce liver disease</keyword>
	<keyword>dosimetry</keyword>
</DOC>